1. Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisa-tion and plasma oestrogen levels in postmenopausal women with breast cancer;Geisler;Br J Cancer,1996
2. Anastrozole, a potent and selective aromatase inhibitor, versus magestrol acetate in postmenopausal women with advanced breast cancer: Results of overview analysis of two phase III trials;Buzdar;J Clin Oncol,1996
3. Significant improved survival with Arimidex® (anastrozole) versus megestrol acetate in postmenopausal advanced breast cancer; Updated results of two randomized trials;Buzdar;J Clin Oncol,1997
4. Significantly improved survival with ‘arimidex’ (anastrozole) compared with megestrol acetate in postmenopausal women with advanced breast cancer: Updated results of two randomized trials;Jonat;Eur J Cancer,1997
5. A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimi-dex)TM with megestrol acetate in postmenopausal patients with advanced breast cancer;Jonat;Eur J Cancer,1996